Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation

British Journal of Dermatology

Volumn 166, Issue 6, 2012, Pages 1230-1236

  Rao, A ^a   Gupta, S ^a   Dinda, A K ^a   Sharma, A ^a   Sharma, V K ^a   Kumar, G ^a   Mitra, D K ^a   Prashant, C K ^a   Singh, G ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; PSORALEN; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; AGED; ARTICLE; AYURVEDA; BLOOD SAMPLING; BODY SURFACE; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HOMEOPATHY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTE TRANSPLANTATION; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCH BIOPSY; PUVA; SKIN PIGMENTATION; SKIN TRANSPLANTATION; SUCTION BLISTER EPIDERMAL GRAFTING; VITILIGO;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD45; CATALASE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTES; MIDDLE AGED; T-LYMPHOCYTES; TREATMENT OUTCOME; VITILIGO; YOUNG ADULT;

EID: 84860565181     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10886.x     Document Type: Article

References (23)

1. Gupta S,. Stability in vitiligo: why such a hullabaloo? J Cutan Aesthet Surg 2009; 2: 41-2.
2. Falabella R, Escobar C, Borrero I, et al. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes. J Am Acad Dermatol 1992; 26: 230-6.
3. Falabella R,. Surgical treatment of vitiligo: why, when and how. J Eur Acad Dermatol Venereol 2003; 17: 518-20.
4. Savant SS,. Autologous miniatures punch grafting in vitiligo. Indian J Dermatol Venereol Leprol 1992; 58: 310-14.
5. Jha AK, Pandey SS, Shukla VK, et al. Punch grafting in vitiligo. Indian J Dermatol Venereol Leprol 1992; 58: 328-30.
6. Boersma BR, Westerhof W,. Repigmentation in vitiligo vulgaris by autologous minigrafting: results in 19 patients. J Am Acad Dermatol 1995; 33: 990-5.
7. Falabella R, Arrunategui A, Barona MI, et al. The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation. J Am Acad Dermatol 1995; 32: 228-32.
8. Lahiri K, Malakar S,. The concept of stability of vitiligo. In: Surgical Management of Vitiligo (, Gupta S, Olsson MJ, Kanwar AJ, Ortonne J-P, eds), 1st edn. Oxford: Blackwell Publishing, 2007; 49-55.
9. Njoo MD, Das PK, Bos JD, et al. Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 1999; 135: 414.
10. Mohanty S, Kumar A, Dhawan J, et al. Noncultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo. Br J Dermatol 2011; 164: 1241-6.
11. Hazneci E, Karabulut A, Ã-ztürk C, et al. A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients. Int J Dermatol 2005; 44: 636-40.
12. Agrawal D, Shajil EM, Marfatia YS, et al. Study on the antioxidant status of vitiligo patients of different age groups in Baroda. Pigment Cell Res 2004; 17: 289-94.
13. Arican O, Kurutas EB,. Oxidative stress in the blood of patients with active vitiligo. Acta Dermatovenerol Alp Panonica Adriat 2008; 17: 12-16.
14. Schallreuter KU, Wood JM, Berger J, et al. Low catalase levels in epidermis of patients with vitiligo. J Invest Dermatol 1991; 97: 1081-5.
15. Maresca V, Roccella M, Roccella F, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997; 109: 310-3.
16. Sravani PV, Babu NK, Gopal KV, et al. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol 2009; 75: 268-71.
17. Passi S, Grandinetti M, Maggio F, et al. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998; 11: 81-5.
18. Ogg GS, Rod DP, Romero P, et al. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 1998; 188: 1203-8.
19. van den Wijngaard RM, Wankowicz-Kalinska A, Le PC, et al. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000; 80: 1299-309.
20. Wankowicz-Kalinska A, van den Wijngaard RM, Tigges BJ, et al. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 2003; 83: 683-95.
21. van den Boorn J G, Konijnenberg D, Dellemijn T, et al. Autoimmune destruction of melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009; 129: 2220-32.
22. Abdallah M, Abdel Naser MB, Moussa MH, et al. Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo. European J Dermatol 2003; 13: 548-52.
23. Klarquist J, Denman CJ, Hernandez C, et al. Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res 2010; 23: 276-86.